Brief: Microport Scientific Posts HY Results For Shanghai Microport Endovascular Medtech
28/07/2023 13:46
July 28 (Reuters) - Microport Scientific Corp 0853.HK :
* HY NET PROFIT ATTRIBUTABLE FOR SHANGHAI MICROPORT
ENDOVASCULAR
MEDTECH RMB279.9 MILLION VERSUS RMB215.0 MILLION
* HY REVENUE OF SHANGHAI MICROPORT ENDOVASCULAR MEDTECH
RMB621.6
MLN VS RMB458.8 MLN
Further company coverage: 0853.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MicroPort Scientific
See all newsBrief: Microport Scientific Says Delay In Publication Of Interim Results
Brief: Microport Scientific Announces Delay In Publication Of 2026 Interim Results
Brief: Microport Scientific Says Shanghai Microport Endovascular Medtech Logs HY Revenue Of RMB793.95 Million
Brief: Microport Scientific Sees 12%-14% Y/Y Revenue Growth In Continuing Operations For HY
Brief: Microport Scientific Unit And Others To Sell 62% Of Shanghai Microport Orthopedics To Tinavi